CR9598A - Moduladores no esteroides de receptor de progesterona - Google Patents

Moduladores no esteroides de receptor de progesterona

Info

Publication number
CR9598A
CR9598A CR9598A CR9598A CR9598A CR 9598 A CR9598 A CR 9598A CR 9598 A CR9598 A CR 9598A CR 9598 A CR9598 A CR 9598A CR 9598 A CR9598 A CR 9598A
Authority
CR
Costa Rica
Prior art keywords
therapy
prevention
receptor modulators
progesterone receptor
steroid progesterone
Prior art date
Application number
CR9598A
Other languages
English (en)
Inventor
Hillisch Alexander
Bothe Ulrich
Kaufmann Guenter
Sobek Lothar
Fuhrmann Ulrike
Droescher Peter
Schmees Norbert
Schwede Wolfgang
Moeller Carsten
Schmidt Anja
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of CR9598A publication Critical patent/CR9598A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/02—1,2-Oxazines; Hydrogenated 1,2-oxazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Se refiere a moduladores no-esteroides de receptor de progesterona de la formula general (I), al proceso para su preparacion, al usode los moduladores del receptor de progesterona para la produccion de medicamentos asi como tambien composiciones farmaceuticas que contienen estos compuestos. Los compuestos segun la invencion son apropiados para la terapia y la prevencion de enfermedades ginecologicas tales como endometriosis, leiomiomas de utero, hemorragias disfuncionales y dismenorrea y para la terapia y la prevencion de tumores dependientes de hormonas y para el uso para el control de la fertilidad femenina y para la terapia de reemplazo hormonal.
CR9598A 2005-06-24 2007-12-17 Moduladores no esteroides de receptor de progesterona CR9598A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005030292A DE102005030292A1 (de) 2005-06-24 2005-06-24 Nichtsteroidale Progesteronrezeptor-Modulatoren

Publications (1)

Publication Number Publication Date
CR9598A true CR9598A (es) 2008-04-09

Family

ID=37199176

Family Applications (1)

Application Number Title Priority Date Filing Date
CR9598A CR9598A (es) 2005-06-24 2007-12-17 Moduladores no esteroides de receptor de progesterona

Country Status (22)

Country Link
EP (1) EP1902049A2 (es)
JP (1) JP2008543910A (es)
KR (1) KR20080030622A (es)
CN (1) CN101248066A (es)
AR (1) AR054519A1 (es)
AU (1) AU2006261048A1 (es)
BR (1) BRPI0611903A2 (es)
CA (1) CA2611897A1 (es)
CR (1) CR9598A (es)
DE (1) DE102005030292A1 (es)
DO (1) DOP2006000148A (es)
EA (1) EA200702524A1 (es)
EC (1) ECSP078044A (es)
GT (1) GT200600271A (es)
IL (1) IL188021A0 (es)
MX (1) MX2008000072A (es)
NO (1) NO20080440L (es)
PE (1) PE20070125A1 (es)
TW (1) TW200740778A (es)
UY (1) UY29624A1 (es)
WO (1) WO2006136461A2 (es)
ZA (1) ZA200800690B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY30805A1 (es) * 2006-12-21 2008-07-31 Bayer Schering Pharma Ag Moduladores no esteroides de receptores de progesterona
DE102007032800A1 (de) * 2007-07-10 2009-01-15 Bayer Schering Pharma Aktiengesellschaft Nichtsteroidale Progesteronrezeptor-Modulatoren
DE102007058747A1 (de) * 2007-12-05 2009-06-10 Bayer Schering Pharma Aktiengesellschaft Nichtsteroidale Progesteronrezeptor-Modulatoren
JP2011519916A (ja) * 2008-07-02 2011-07-14 ファーマコステック カンパニー リミテッド アミド誘導体の製造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19856475A1 (de) * 1998-11-27 2000-05-31 Schering Ag Nichtsteroidale Entzündungshemmer
EP1344776A1 (en) * 2002-03-11 2003-09-17 Schering Aktiengesellschaft 5- 2-hydroxy-3-[1-(3-trifluoromethylphenyl)-cyclopropyl]-propionylamino -phtalide and 6- 2-hydroxy-3-[1-(3-trifluoromethylphenyl)-cyclopropyl]-propionylamino -4-methyl-2,3-benzoxazin-1-one derivatives with progesterone receptor modulating activity for use in fertility control, hormone replacement therapy and the treatment of gynecological disorders
BRPI0412231A (pt) * 2003-07-01 2006-08-22 Schering Ag derivados de pentanol substituìdos heterociclicamente, processos para a sua preparação e sua aplicação como inibidores de inflamação

Also Published As

Publication number Publication date
EP1902049A2 (en) 2008-03-26
PE20070125A1 (es) 2007-02-14
KR20080030622A (ko) 2008-04-04
EA200702524A1 (ru) 2008-06-30
BRPI0611903A2 (pt) 2010-10-05
TW200740778A (en) 2007-11-01
CN101248066A (zh) 2008-08-20
JP2008543910A (ja) 2008-12-04
NO20080440L (no) 2008-03-25
MX2008000072A (es) 2008-03-24
GT200600271A (es) 2007-02-05
ECSP078044A (es) 2008-01-23
WO2006136461A2 (en) 2006-12-28
WO2006136461A3 (en) 2007-03-15
DE102005030292A1 (de) 2007-01-11
DOP2006000148A (es) 2007-07-15
UY29624A1 (es) 2007-01-31
CA2611897A1 (en) 2006-12-28
IL188021A0 (en) 2008-03-20
ZA200800690B (en) 2009-09-30
AU2006261048A1 (en) 2006-12-28
AR054519A1 (es) 2007-06-27

Similar Documents

Publication Publication Date Title
AR054586A1 (es) Uso de moduladores del receptor de progesterona
CU20120175A7 (es) Compuestos derivados de 6,7-dihidro-5h-benzo[7]anulenos
ECSP18047708A (es) Derivados de 17-hidroxi-17-pentafluoroetil-estra-4,9(10)-dien-11-arilo como antagonistas de progesterona y procedimientos para su preparación
CR10875A (es) Derivados de ester y amida de indazolilo para el tratamiento de enfermedades mediadas por un receptor de glucocorticoides
ECSP034428A (es) Ciclopentanoindoles, composiciones conteniendo tales compuestos y su uso
SV2010003580A (es) Agonistas novedosos de los receptores de glucocorticoides
ECSP055574A (es) Uso de derivados de tio-oxindol en el tratamiento de condiciones relacionadas con hormonas.
ECSP078043A (es) Derivados de benzofurarona como moduladores no esteroides de receptores de progesterona
WO2011098437A3 (de) Progesteronrezeptorantagonisten
CR9598A (es) Moduladores no esteroides de receptor de progesterona
DOP2006000147A (es) Uso de modulares no esteroides de receptores de progesterona.
CR9627A (es) Cyanopyrrole-sulfonamide progesterone receptor modulators and uses thereof
UY30805A1 (es) Moduladores no esteroides de receptores de progesterona
SV2011003817A (es) Derivados de estratrieno que comprenden bioisosteros heterociclicos para el anillo fenolico a
UY30815A1 (es) Moduladores no esteroidales del receptor de progesterona
CU20090109A7 (es) Derivados de éster y amida de indazolilo para el tratamiento de enfermedades mediadas por un receptor de glucocorticoides

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)